POLYMED1,749.00

Poly Medicure Ltd.

· Pharma & Health
₹ CrorePeersPFIZERRAINBOWONESOURCEKIMSJUBLPHARMAVIJAYAINDGNGRANULESMcap ₹17,728 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
POLYMED
FY26
PFIZER
FY26
RAINBOW
FY26
ONESOURCE
FY26
Peer
Median
Valuation — at last close
P/E55.02×53.34×53.34× +3%
P/B5.63×8.92×3.04×5.98× -6%
EV/EBITDA39.06×26.48×62.39×44.43× -12%
Market Cap₹17,728 Cr₹14,848 Cr₹17,744 Cr₹16,296 Cr +9%
Growth
Revenue CAGR 3Y18.91%1.29%13.22%7.26% +161%
Revenue CAGR 5Y18.98%2.39%2.39% +694%
Net Income CAGR 3Y21.39%5.01%9.85%7.43% +188%
Revenue YoY (latest Q)30.30%33.17%37.20%35.19% -14%
Net Income YoY (latest Q)-8.39%16.23%13539.25%6777.74% -100%
Profitability
EBITDA Margin23.59%35.88%31.95%21.40%31.95% -26%
Net Income Margin17.10%28.67%16.53%-5.19%16.53% +3%
Return on Common Equity10.23%17.19%16.73%-1.27%16.73% -39%
Return on Capital Employed9.78%19.71%15.19%0.37%15.19% -36%
Return on Assets8.18%14.68%10.15%-0.90%10.15% -19%
Credit & Quality
Total Debt/Equity0.11×0.00×0.00×0.22×0.00×
Interest Coverage17.87×89.28×5.07×0.21×5.07× +252%
Scale — latest FY
Revenue / Total Income₹1,875 Cr₹2,520 Cr₹1,703 Cr₹1,422 Cr₹1,703 Cr +10%
Net Income₹321 Cr₹722 Cr₹282 Cr−₹73.8 Cr₹282 Cr +14%
Total Assets₹3,919 Cr₹4,922 Cr₹2,775 Cr₹8,210 Cr₹4,922 Cr -20%
EPS₹31.79₹27.41₹-6.44₹10.49 +203%
Book Value per Share₹310.7₹163.81₹508.75₹336.28 -8%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.